Skip to main content
. 2017 Jun 27;8(44):76057–76068. doi: 10.18632/oncotarget.18648

Figure 6. The expression of miR-494 is negatively correlated with survival time of breast cancer patients.

Figure 6

The correlation between miR-494 expression and overall survival in a GSE37405 dataset of ER+ breast cancer patients (A) or metastasis free survival in TCGA invasive breast cancer dataset (B) was analyzed by MIRUMIR or PROGmiR V2 website.